Sex-Associated Differences in Cytomegalovirus Prevention: Prophylactic Strategy is Potentially Associated With a Strong Kidney Function Impairment in Female Renal Transplant Patients

• Main Authors: Arturo Blazquez-Navarro (Author), Chantip Dang-Heine (Author), Chris Bauer (Author), Nicole Wittenbrink (Author), Kerstin Wolk (Author), Robert Sabat (Author), Oliver Witzke (Author), Timm H. Westhoff (Author), Birgit Sawitzki (Author), Petra Reinke (Author), Oliver Thomusch (Author), Christian Hugo (Author), Nina Babel (Author), Michal Or-Guil (Author)
• Format: Book
• Published: Frontiers Media S.A., 2020-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Post-transplantation cytomegalovirus (CMV) syndrome can be prevented using the antiviral drug (val)ganciclovir. (Val)ganciclovir is typically administered following a prophylactic or a pre-emptive strategy. The prophylactic strategy entails early universal administration, the pre-emptive strategy, e...